Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Kamada Ltd.

Kamada Ltd. (KMDA) Stock Overview

Explore Kamada Ltd.’s financial performance, market position, analyst ratings, and future outlook.

KMDA●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$7.85
$0.24(3.15%)
U.S. Market opens in 6h 11m

Kamada Ltd. (KMDA)

Meyka AI Score

Z

Key Financials

Market Cap452.9M
P/E Ratio20.38
EPS (TTM)$0.38
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$7.94
3 Months$8.28
1 Year Target$8.86

KMDA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Kamada Ltd. (NASDAQ: KMDA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Kamada Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of KMDA on the NASDAQ shows an RSI of 44.63, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $8.86 for the NASDAQ listing.

Key metrics behind Kamada Ltd.'s NASDAQ-traded stock include a P/E ratio of 20.38 and a market capitalization of 452.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of KMDA on the NASDAQ.

Price Performance (NASDAQ: KMDA)

1-Day Change
3.15%
5-Day Change
2.48%
1-Month Change
-11.30%
3-Month Change
10.72%
6-Month Change
-5.65%
Year-to-Date (YTD) Change
11.19%
1-Year Change
10.88%
3-Year Change
80.05%
5-Year Change
45.37%
All-Time (Max) Change
-25.52%

Contact Information

https://www.kamada.com
972 8 940 6472
2 Holzman Street, Rehovot, HM, 7670402

Company Facts

4,620 Employees
IPO DateMay 31, 2013
CountryIL
Actively Trading

Frequently Asked Questions